Join us for our webcast, Navigating Increased Scrutiny for Health Care Deals in 2024. Together with Sheppard Mullins and America’s Physician Groups, we’ll address the new pressures facing health care systems, private equity investors, providers, and other stakeholders looking to complete a transaction in the health care ecosystem. We’ll discuss:
- How health care deals are being examined and reviewed by the Department of Justice (DOJ), the Federal Trade Commission (FTC)—and now, the Department of Health and Human Services (HHS).
- What’s new for transactional review and regulatory filings at the state level
- Unintended consequences this increased transactional scrutiny and added regulatory burden might have on market dynamics, deal confidentiality, and financially stressed organizations looking for survival options
- Tension between reimbursement models and transaction pullbacks